REFERENCES- Blass, J. P., "Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities," Neurobiol.Aging, Vol. 23, No. 6, 2002, pp. 1077-1084.
- Mayo Clinic on Alzheimer's Disease. Petersen, R. 2002. New York, Mayo Clinic Health Information.
- Morgan, D., "The intersection of Alzheimer's disease and typical aging," Neurobiol.Aging, Vol. 22, No. 1, 2001, pp. 159-160.
- Brookmeyer, R., Corrada, M. M., Curriero, F. C., and Kawas, C., "Survival following a diagnosis of Alzheimer disease," Arch.Neurol., Vol. 59, No. 11, 2002, pp. 1764-1767.
- Kammoun, S., Gold, G., Bouras, C., Giannakopoulos, P., McGee, W., Herrmann, F., and Michel, J. P., "Immediate causes of death of demented and non-demented elderly," Acta Neurol.Scand.Suppl, Vol. 176, 2000, pp. 96-99.
- Cummings, J. L.. Neuropsychiatry of Alzheimer's Disease and Related Dementia. 2003. London, Martin Dunlitz.
- Petrella, J. R., Coleman, R. E., and Doraiswamy, P. M., "Neuroimaging and early diagnosis of Alzheimer disease: a look to the future," Radiology, Vol. 226, No. 2, 2003, pp. 315-336.
- Felber, S. R., "Magnetic resonance in the differential diagnosis of dementia," J Neural Transm., Vol. 109, No. 7-8, 2002, pp. 1045-1051.
- Cohen, E.. Alzheimer's Disease. 1999. Los Angeles, Keats Publishing.
- Mayeux, R. and Sano, M., "Treatment of Alzheimer's disease," The New England Journal of Medicine, Vol. 341, No. 22, 1999, pp. 1670-1679.
- Brookmeyer, R., Gray, S., and Kawas, C., "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset," Am J Public Health, Vol. 88, No. 9, 1998, pp. 1337-1342.
- in, t., V, Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M., and Stricker, B. H., "Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease," The New England Journal of Medicine, Vol. 345, No. 21, 2001, pp. 1515-1521.
- Vagnucci, A. H., Jr. and Li, W. W., "Alzheimer's disease and angiogenesis," Lancet, Vol. 361, No. 9357, 2003, pp. 605-608.
- Selkoe, D. J., "Alzheimer's disease is a synaptic failure," Science, Vol. 298, No. 5594, 2002, pp. 789-791.
- Robinson, S. R. and Bishop, G. M., "Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease," Neurobiol.Aging, Vol. 23, No. 6, 2002, pp. 1051-1072.
- Royall, D. R., "Alzheimer disease as a vascular disorder: nosological evidence," Stroke, Vol. 33, No. 9, 2002, pp. 2147-2148.
- Kalaria, R., "Similarities between Alzheimer's disease and vascular dementia," J Neurol.Sci, Vol. 203-204, 2002, pp. 29-34.
- de la Torre, J. C., "Alzheimer disease as a vascular disorder: nosological evidence," Stroke, Vol. 33, No. 4, 2002, pp. 1152-1162.
- de la Torre, J. C., "Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease," Ann N Y.Acad Sci, Vol. 924, 2000, pp. 136-152.
- Roman, G. C., "Vascular dementia may be the most common form of dementia in the elderly," J Neurol.Sci, Vol. 203-204, 2002, pp. 7-10.
- Breteler, M. M., "Vascular risk factors for Alzheimer's disease: an epidemiologic perspective," Neurobiol.Aging, Vol. 21, No. 2, 2000, pp. 153-160.
- de la Torre, J. C., "Alzheimer's disease: How does it start?," J Alzheimers.Dis., Vol. 4, No. 6, 2002, pp. 497-512.
- Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., and Breteler, M. M., "Silent brain infarcts and the risk of dementia and cognitive decline," The New England Journal of Medicine, Vol. 348, No. 13, 2003, pp. 1215-1222.
- Blass, J. P. and Ratan, R. R., ""Silent" strokes and dementia," The New England Journal of Medicine, Vol. 348, No. 13, 2003, pp. 1277-1278.
- Ritchie, K. and Touchon, J., "Mild cognitive impairment: conceptual basis and current nosological status," Lancet, Vol. 355, No. 9199, 2000, pp. 225-228.
- Shah, Y., Tangalos, E. G., and Petersen, R. C., "Mild cognitive impairment. When is it a precursor to Alzheimer's disease?," Geriatrics, Vol. 55, No. 9, 2000, pp. 62, 65-62, 68.
- Fotuhi, M.. The Memory Cure. 2003. New York, McGraw Hill.
- Larrieu, S., Letenneur, L., Orgogozo, J. M., Fabrigoule, C., Amieva, H., Le Carret, N., Barberger-Gateau, P., and Dartigues, J. F., "Incidence and outcome of mild cognitive impairment in a population-based prospective cohort," Neurology, Vol. 59, No. 10, 2002, pp. 1594-1599.
- Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., and Kokmen, E., "Mild cognitive impairment: clinical characterization and outcome," Arch.Neurol., Vol. 56, No. 3, 1999, pp. 303-308.
- Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., and Morris, J. C., "Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease," Arch.Neurol., Vol. 58, No. 9, 2001, pp. 1395-1402.
- Snowdon, D. A., "Aging and Alzheimer's disease: lessons from the Nun Study," Gerontologist, Vol. 37, No. 2, 1997, pp. 150-156.
- Burns, A. and Zaudig, M., "Mild cognitive impairment in older people," Lancet, Vol. 360, No. 9349, 2002, pp. 1963-1965.
- Palmer, K., Wang, H. X., Backman, L., Winblad, B., and Fratiglioni, L., "Differential Evolution of Cognitive Impairment in Nondemented Older Persons: Results From the Kungsholmen Project," American Journal of Psychiatry, Vol. 159, No. 3, 2002, pp. 436-442.
- O'Meara, E. S., Kukull, W. A., Sheppard, L., Bowen, J. D., McCormick, W. C., Teri, L., Pfanschmidt, M., Thompson, J. D., Schellenberg, G. D., and Larson, E. B., "Head injury and risk of Alzheimer's disease by apolipoprotein E genotype," Am J Epidemiol., Vol. 146, No. 5, 1997, pp. 373-384.
- Guo, Z., Cupples, L. A., Kurz, A., Auerbach, S. H., Volicer, L., Chui, H., Green, R. C., Sadovnick, A. D., Duara, R., DeCarli, C., Johnson, K., Go, R. C., Growdon, J. H., Haines, J. L., Kukull, W. A., and Farrer, L. A., "Head injury and the risk of AD in the MIRAGE study," Neurology, Vol. 54, No. 6, 2000, pp. 1316-1323.
- Esposito, E., Rotilio, D., Di, M., V, Di Giulio, C., Cacchio, M., and Algeri, S., "A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes," Neurobiol.Aging, Vol. 23, No. 5, 2002, pp. 719-735.
- Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M., "Dietary intake of antioxidants and risk of Alzheimer disease," JAMA, Vol. 287, No. 24, 2002, pp. 3223-3229.
- Grundman, M., Grundman, M., and Delaney, P., "Antioxidant strategies for Alzheimer's disease," Proc.Nutr Soc., Vol. 61, No. 2, 2002, pp. 191-202.
- Martin, A., "Antioxidant vitamins E and C and risk of Alzheimer's disease," Nutr Rev., Vol. 61, No. 2, 2003, pp. 69-73.
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W., and Wolf, P. A., "Plasma homocysteine as a risk factor for dementia and Alzheimer's disease," The New England Journal of Medicine, Vol. 346, No. 7, 2002, pp. 476-483.
- Payette, H., Boutier, V., Coulombe, C., and Gray-Donald, K., "Benefits of nutritional supplementation in free-living, frail, undernourished elderly people: a prospective randomized community trial," J Am Diet.Assoc., Vol. 102, No. 8, 2002, pp. 1088-1095.
- Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., Wilson, R. S., and Scherr, P. A., "Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study," JAMA, Vol. 287, No. 24, 2002, pp. 3230-3237.
- Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., and Grobbee, D. E., "Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study," Lancet, Vol. 349, No. 9046, 1997, pp. 151-154.
- Korol, D. L., "Enhancing cognitive function across the life span," Ann N Y.Acad Sci, Vol. 959, 2002, pp. 167-179.
- Small, G. W., "Brain-imaging surrogate markers for detection and prevention of age-related memory loss," J Mol.Neurosci., Vol. 19, No. 1-2, 2002, pp. 17-21.
- Peila, R., Rodriguez, B. L., and Launer, L. J., "Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study," Diabetes, Vol. 51, No. 4, 2002, pp. 1256-1262.
- Stewart, R. and Liolitsa, D., "Type 2 diabetes mellitus, cognitive impairment and dementia," Diabet.Med, Vol. 16, No. 2, 1999, pp. 93-112.
- Convit, A., Wolf, O. T., Tarshish, C., and de Leon, M. J., "Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly," Proc.Natl.Acad Sci U.S.A, Vol. 100, No. 4, 2003, pp. 2019-2022.
- Strachan, M. W., Frier, B. M., and Deary, I. J., "Type 2 diabetes and cognitive impairment," Diabet.Med, Vol. 20, No. 1, 2003, pp. 1-2.
- Yanagisawa, K., "Cholesterol and pathological processes in Alzheimer's disease," J Neurosci.Res., Vol. 70, No. 3, 2002, pp. 361-366.
- Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S., and Drachman, D. A., "Statins and the risk of dementia," Lancet, Vol. 356, No. 9242, 2000, pp. 1627-1631.
- Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G., and Siegel, G., "Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors," Arch.Neurol., Vol. 57, No. 10, 2000, pp. 1439-1443.
- Kivipelto, M., Helkala, E. L., Hanninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., and Nissinen, A., "Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study," Neurology, Vol. 56, No. 12, 2001, pp. 1683-1689.
- Notkola, I. L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., and Nissinen, A., "Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease," Neuroepidemiology, Vol. 17, No. 1, 1998, pp. 14-20.
- Wolozin, B., "Cholesterol and Alzheimer's disease," Biochem.Soc.Trans., Vol. 30, No. 4, 2002, pp. 525-529.
- Whyte, E. M., Mulsant, B. H., Butters, M. A., Qayyum, M., Towers, A., Sweet, R. A., Klunk, W., Wisniewski, S., and DeKosky, S. T., "Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia," Am J Geriatr.Psychiatry, Vol. 10, No. 3, 2002, pp. 321-327.
- Mattson, M. P., Kruman, I. I., and Duan, W., "Folic acid and homocysteine in age-related disease," Ageing Res.Rev., Vol. 1, No. 1, 2002, pp. 95-111.
- Selhub, J., Bagley, L. C., Miller, J., and Rosenberg, I. H., "B vitamins, homocysteine, and neurocognitive function in the elderly," American Journal of Clinical Nutrition, Vol. 71, No. 2, 2000, pp. 614S-620S.
- Johnson, M. A., Hawthorne, N. A., Brackett, W. R., Fischer, J. G., Gunter, E. W., Allen, R. H., and Stabler, S. P., "Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services," American Journal of Clinical Nutrition, Vol. 77, No. 1, 2003, pp. 211-220.
- Wang, H. X., Wahlin, A., Basun, H., Fastbom, J., Winblad, B., and Fratiglioni, L., "Vitamin B(12) and folate in relation to the development of Alzheimer's disease," Neurology, Vol. 56, No. 9, 2001, pp. 1188-1194.
- Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., and Ueland, P. M., "Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease," Arch.Neurol., Vol. 55, No. 11, 1998, pp. 1449-1455.
- Snowdon, D. A., Tully, C. L., Smith, C. D., Riley, K. P., and Markesbery, W. R., "Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study," American Journal of Clinical Nutrition, Vol. 71, No. 4, 2000, pp. 993-998.
- Miller, J. W., "Vitamin B12 deficiency, tumor necrosis factor-alpha, and epidermal growth factor: a novel function for vitamin B12?," Nutr Rev., Vol. 60, No. 5 Pt 1, 2002, pp. 142-144.
- Weir, D. G. and Molloy, A. M., "Microvascular disease and dementia in the elderly: are they related to hyperhomocysteinemia?," American Journal of Clinical Nutrition, Vol. 71, No. 4, 2000, pp. 859-860.
- Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., and Fisher, R. H., "Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment," Lipids, Vol. 35, No. 12, 2000, pp. 1305-1312.
- Kyle, D. J., Schaefer, E., Patton, G., and Beiser, A., "Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia," Lipids, Vol. 34 Suppl, 1999, pp. S245.
- Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., and Gibney, M. J., "Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study," Br.J Nutr, Vol. 89, No. 4, 2003, pp. 483-489.
- Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A., and Breteler, M. M., "Dietary fat intake and the risk of incident dementia in the Rotterdam Study," Ann Neurol., Vol. 42, No. 5, 1997, pp. 776-782.
- Yehuda, S., Rabinovitz, S., Carasso, R. L., and Mostofsky, D. I., "The role of polyunsaturated fatty acids in restoring the aging neuronal membrane," Neurobiol.Aging, Vol. 23, No. 5, 2002, pp. 843-853.
- Suter, O. C., Sunthorn, T., Kraftsik, R., Straubel, J., Darekar, P., Khalili, K., and Miklossy, J., "Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease," Stroke, Vol. 33, No. 8, 2002, pp. 1986-1992.
- Zuccala, G., Onder, G., Pedone, C., Carosella, L., Pahor, M., Bernabei, R., and Cocchi, A., "Hypotension and cognitive impairment: Selective association in patients with heart failure," Neurology, Vol. 57, No. 11, 2001, pp. 1986-1992.
- Harrington, F., Saxby, B. K., McKeith, I. G., Wesnes, K., and Ford, G. A., "Cognitive performance in hypertensive and normotensive older subjects," Hypertension, Vol. 36, No. 6, 2000, pp. 1079-1082.
- Morris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., and Evans, D. A., "Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study," Arch.Neurol., Vol. 58, No. 10, 2001, pp. 1640-1646.
- Posner, H. B., Tang, M. X., Luchsinger, J., Lantigua, R., Stern, Y., and Mayeux, R., "The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function," Neurology, Vol. 58, No. 8, 2002, pp. 1175-1181.
- Peters, R., "The prevention of dementia," J Cardiovasc.Risk, Vol. 8, No. 5, 2001, pp. 253-256.
- Kilander, L., Nyman, H., Boberg, M., Hansson, L., and Lithell, H., "Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men," Hypertension, Vol. 31, No. 3, 1998, pp. 780-786.
- Forette, F., Seux, M. L., Staessen, J. A., Thijs, L., Babarskiene, M. R., Babeanu, S., Bossini, A., Fagard, R., Gil-Extremera, B., Laks, T., Kobalava, Z., Sarti, C., Tuomilehto, J., Vanhanen, H., Webster, J., Yodfat, Y., and Birkenhager, W. H., "The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study," Arch.Intern.Med, Vol. 162, No. 18, 2002, pp. 2046-2052.
- Amenta, F., Mignini, F., Rabbia, F., Tomassoni, D., and Veglio, F., "Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data," J Neurol.Sci, Vol. 203-204, 2002, pp. 147-151.
- Mukamal, K. J., Kuller, L. H., Fitzpatrick, A. L., Longstreth, W. T., Jr., Mittleman, M. A., and Siscovick, D. S., "Prospective study of alcohol consumption and risk of dementia in older adults," JAMA, Vol. 289, No. 11, 2003, pp. 1405-1413.
- Russo, A., Palumbo, M., Aliano, C., Lempereur, L., Scoto, G., and Renis, M., "Red wine micronutrients as protective agents in Alzheimer-like induced insult," Life Sci, Vol. 72, No. 21, 2003, pp. 2369-2379.
- Ruitenberg, A., van Swieten, J. C., Witteman, J. C., Mehta, K. M., van Duijn, C. M., Hofman, A., and Breteler, M. M., "Alcohol consumption and risk of dementia: the Rotterdam Study," Lancet, Vol. 359, No. 9303, 2002, pp. 281-286.
- Truelsen, T., Thudium, D., and Gronbaek, M., "Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study," Neurology, Vol. 59, No. 9, 2002, pp. 1313-1319.
- Willett, W. C.. Eat, Drink and Be Healthy. The Harvard Medical School Guide to Healthy Eating. 2001. Fireside, New York.
- Schmidt, R., Schmidt, H., and Fazekas, F., "Vascular risk factors in dementia," J Neurol., Vol. 247, No. 2, 2000, pp. 81-87.
- Ott, A., Breteler, M. M., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., and Hofman, A., "Atrial fibrillation and dementia in a population-based study. The Rotterdam Study," Stroke, Vol. 28, No. 2, 1997, pp. 316-321.
- Sabatini, T., Barbisoni, P., Rozzini, R., and Trabucchi, M., "Hypotension and cognitive impairment: selective association in patients with heart failure," Neurology, Vol. 59, No. 4, 2002, pp. 651.
- Kilander, L., Andren, B., Nyman, H., Lind, L., Boberg, M., and Lithell, H., "Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men," Stroke, Vol. 29, No. 9, 1998, pp. 1816-1820.
- Wilson, R. S., Mendes De Leon, C. F., Barnes, L. L., Schneider, J. A., Bienias, J. L., Evans, D. A., and Bennett, D. A., "Participation in cognitively stimulating activities and risk of incident Alzheimer disease," JAMA, Vol. 287, No. 6, 2002, pp. 742-748.
- Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., "Effects of cognitive training interventions with older adults: a randomized controlled trial," JAMA, Vol. 288, No. 18, 2002, pp. 2271-2281.
- Wilson, R. S., Bennett, D. A., Bienias, J. L., Aggarwal, N. T., Mendes De Leon, C. F., Morris, M. C., Schneider, J. A., and Evans, D. A., "Cognitive activity and incident AD in a population-based sample of older persons," Neurology, Vol. 59, No. 12, 2002, pp. 1910-1914.
- Friedland, R. P., Fritsch, T., Smyth, K. A., Koss, E., Lerner, A. J., Chen, C. H., Petot, G. J., and Debanne, S. M., "Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members," Proc.Natl.Acad Sci U.S.A, Vol. 98, No. 6, 2001, pp. 3440-3445.
- Qiu, C., Karp, A., Von Strauss, E., Winblad, B., Fratiglioni, L., and Bellander, T., "Lifetime principal occupation and risk of Alzheimer's disease in the Kungsholmen project," Am J Ind.Med, Vol. 43, No. 2, 2003, pp. 204-211.
- Snowdon, D. A., Greiner, L. H., and Markesbery, W. R., "Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study," Ann N Y.Acad Sci, Vol. 903, 2000, pp. 34-38.
- Davis, R. N., Massman, P. J., and Doody, R. S., "Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study," Alzheimer Dis.Assoc.Disord., Vol. 15, No. 1, 2001, pp. 1-9.
- Gauthier, E., Fortier, I., Courchesne, F., Pepin, P., Mortimer, J., and Gauvreau, D., "Aluminum forms in drinking water and risk of Alzheimer's disease," Environ.Res., Vol. 84, No. 3, 2000, pp. 234-246.
- Rondeau, V., Commenges, D., Jacqmin-Gadda, H., and Dartigues, J. F., "Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study," Am J Epidemiol., Vol. 152, No. 1, 2000, pp. 59-66.
- Newman, P. E., "Alzheimer's disease revisited," Med Hypotheses, Vol. 54, No. 5, 2000, pp. 774-776.
- Savory, J. and Garruto, R. M., "Aluminum, tau protein, and Alzheimer's disease: an important link?," Nutrition, Vol. 14, No. 3, 1998, pp. 313-314.
- Mate, G.. When The Body Says No. 2003. New Jarsey, John Wiley and Sons.
- Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., and Glaser, R., "Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology," Annu.Rev.Psychol., Vol. 53, 2002, pp. 83-107.
- McGeer, P. L. and McGeer, E. G., "Autotoxicity and Alzheimer disease," Arch.Neurol., Vol. 57, No. 6, 2000, pp. 789-790.
- Hock, C., Drasch, G., Golombowski, S., Muller-Spahn, F., Willershausen-Zonnchen, B., Schwarz, P., Hock, U., Growdon, J. H., and Nitsch, R. M., "Increased blood mercury levels in patients with Alzheimer's disease," J Neural Transm., Vol. 105, No. 1, 1998, pp. 59-68.
- Ely, J. T., "Mercury induced Alzheimer's disease: accelerating incidence?," Bull.Environ.Contam Toxicol., Vol. 67, No. 6, 2001, pp. 800-806.
- Saxe, S. R., Wekstein, M. W., Kryscio, R. J., Henry, R. G., Cornett, C. R., Snowdon, D. A., Grant, F. T., Schmitt, F. A., Donegan, S. J., Wekstein, D. R., Ehmann, W. D., and Markesbery, W. R., "Alzheimer's disease, dental amalgam and mercury," J Am Dent.Assoc., Vol. 130, No. 2, 1999, pp. 191-199.
- Baldi, I., Lebailly, P., Mohammed-Brahim, B., Letenneur, L., Dartigues, J. F., and Brochard, P., "Neurodegenerative diseases and exposure to pesticides in the elderly," Am J Epidemiol., Vol. 157, No. 5, 2003, pp. 409-414.
- Hebert, R., Lindsay, J., Verreault, R., Rockwood, K., Hill, G., and Dubois, M. F., "Vascular dementia : incidence and risk factors in the Canadian study of health and aging," Stroke, Vol. 31, No. 7, 2000, pp. 1487-1493.
- Epstein, S. S.. The Politics of Cancer Revisited. 1998. East Ridge Press.
- Cummings, J. L., "Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations," Am J Geriatr.Psychiatry, Vol. 11, No. 2, 2003, pp. 131-145.
- Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S., Thal, L. J., and The Members of the Alzheimer's Disease Cooperative Study, "A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease," The New England Journal of Medicine, Vol. 336, No. 17, 1997, pp. 1216-1222.
- Jiang, Q., Christen, S., Shigenaga, M. K., and Ames, B. N., "gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention," American Journal of Clinical Nutrition, Vol. 74, No. 6, 2001, pp. 714-722.
- Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M., "Dietary intake of antioxidants and risk of Alzheimer disease," JAMA, Vol. 287, No. 24, 2002, pp. 3223-3229.
- Grodstein, F., Chen, J., and Willett, W. C., "High-dose antioxidant supplements and cognitive function in community-dwelling elderly women," American Journal of Clinical Nutrition, Vol. 77, No. 4, 2003, pp. 975-984.
- Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., and Wilson, R. S., "Vitamin E and cognitive decline in older persons," Arch.Neurol., Vol. 59, No. 7, 2002, pp. 1125-1132.
- Ortega, R. M., Requejo, A. M., Lopez-Sobaler, A. M., Andres, P., Navia, B., Perea, J. M., and Robles, F., "Cognitive function in elderly people is influenced by vitamin E status," J Nutr, Vol. 132, No. 7, 2002, pp. 2065-2068.
- Kontush, A., Mann, U., Arlt, S., Ujeyl, A., Luhrs, C., Muller-Thomsen, T., and Beisiegel, U., "Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease," Free Radic.Biol.Med, Vol. 31, No. 3, 2001, pp. 345-354.
- Masaki, K. H., Losonczy, K. G., Izmirlian, G., Foley, D. J., Ross, G. W., Petrovitch, H., Havlik, R., and White, L. R., "Association of vitamin E and C supplement use with cognitive function and dementia in elderly men," Neurology, Vol. 54, No. 6, 2000, pp. 1265-1272.
- Abyad, A., "Prevalence of Vitamin B12 Deficiency Among Demented Patients and Cognitive Recovery with Cobalamin Replacement," J Nutr Health Aging, Vol. 6, No. 4, 2002, pp. 254-260.
- Eastley, R., Wilcock, G. K., and Bucks, R. S., "Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function," Int.J Geriatr.Psychiatry, Vol. 15, No. 3, 2000, pp. 226-233.
- Kuzminski, A. M., Del Giacco, E. J., Allen, R. H., Stabler, S. P., and Lindenbaum, J., "Effective treatment of cobalamin deficiency with oral cobalamin," Blood, Vol. 92, No. 4, 1998, pp. 1191-1198.
- Kris-Etherton, P. M., Harris, W. S., and Appel, L. J., "Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association," Arterioscler.Thromb.Vasc.Biol., Vol. 23, No. 2, 2003, pp. 151-152.
- Kris-Etherton, P. M., Harris, W. S., and Appel, L. J., "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease," Arterioscler.Thromb.Vasc.Biol., Vol. 23, No. 2, 2003, pp. e20-e30.
- Sears, B.. The Omega Rx Zone. 2002. New York, Harper-Collins.
- Hu, F. B. and Willett, W. C., "Optimal diets for prevention of coronary heart disease," JAMA, Vol. 288, No. 20, 2002, pp. 2569-2578.
- Yehuda, S., Rabinovtz, S., Carasso, R. L., and Mostofsky, D. I., "Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life," Int.J Neurosci., Vol. 87, No. 3-4, 1996, pp. 141-149.
- Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., and Hirayama, T., "Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases," Lipids, Vol. 34 Suppl, 1999, pp. S345-S346.
- Peers, R. J., "Alzheimer's disease and omega-3 fatty acids: hypothesis," Med J Aust., Vol. 153, No. 9, 1990, pp. 563-564.
- Birks, J., Grimley, E. V., and Van Dongen, M., "Ginkgo biloba for cognitive impairment and dementia," Cochrane.Database.Syst.Rev., No. 4, 2002, pp. CD003120.
- Andrieu, S., Gillette, S., Amouyal, K., Nourhashemi, F., Reynish, E., Ousset, P. J., Albarede, J. L., Vellas, B., and Grandjean, H., "Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study," J Gerontol.A Biol.Sci Med Sci, Vol. 58, No. 4, 2003, pp. 372-377.
- Solomon, P. R., Adams, F., Silver, A., Zimmer, J., and DeVeaux, R., "Ginkgo for memory enhancement: a randomized controlled trial," JAMA, Vol. 288, No. 7, 2002, pp. 835-840.
- Nathan, P. J., Harrison, B. J., and Bartholomeusz, C., "Ginkgo and memory," JAMA, Vol. 289, No. 5, 2003, pp. 546-548.
- Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., and Butko, P., "Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761," Proc.Natl.Acad Sci U.S.A, Vol. 99, No. 19, 2002, pp. 12197-12202.
- Fassbender, K., Masters, C., and Beyreuther, K., "Alzheimer's disease: an inflammatory disease?," Neurobiol.Aging, Vol. 21, No. 3, 2000, pp. 433-436.
- Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R., McGeer, P. L., O'Banion, M. K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F. L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., and Wyss-Coray, T., "Inflammation and Alzheimer's disease," Neurobiol.Aging, Vol. 21, No. 3, 2000, pp. 383-421.
- McGeer, P. L., Schulzer, M., and McGeer, E. G., "Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies," Neurology, Vol. 47, No. 2, 1996, pp. 425-432.
- Zandi, P. P. and Breitner, J. C., "Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence," Neurobiol.Aging, Vol. 22, No. 6, 2001, pp. 811-817.
- Launer, L., "Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease : dissecting the epidemiological evidence," Drugs, Vol. 63, No. 8, 2003, pp. 731-739.
- Shumaker, S. A., Legault, C., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones, B. N., III, Assaf, A. R., Jackson, R. D., Morley, K. J., Wassertheil-Smoller, S., and Wactawski-Wende, J., "Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial," JAMA, Vol. 289, No. 20, 2003, pp. 2651-2662.
- Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L., Stefanick, M. L., Lane, D. S., Hays, J., Johnson, K. C., Coker, L. H., Dailey, M., and Bowen, D., "Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial," JAMA, Vol. 289, No. 20, 2003, pp. 2663-2672.
- Banaclocha, M. M., "Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases," Med Hypotheses, Vol. 56, No. 4, 2001, pp. 472-477.
- Atkins, R. C.. Dr. Atkins' Vita-Nutrient Solution. 1998. New York, Simon and Schuster.
- Packer, L.. The Antioxidant Miracle. 1999. New York, John Wiley & Sons.
- Hager, K., Marahrens, A., Kenklies, M., Riederer, P., and Munch, G., "Alpha-lipoic acid as a new treatment option for Azheimer type dementia," Arch.Gerontol.Geriatr., Vol. 32, No. 3, 2001, pp. 275-282.
- Berkson, B.. The Alpha Lipoic Acid Breakthrough. 1998. California, Prima Communications.
- Pope, S. K., Shue, V. M., and Beck, C., "Will a healthy lifestyle help prevent alzheimer's disease?," Annu.Rev.Public Health, Vol. 24, 2003, pp. 111-132.
- Chertkow, H., "Mild cognitive impairment," Curr.Opin.Neurol., Vol. 15, No. 4, 2002, pp. 401-407.
- Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., and Winblad, B., "Current concepts in mild cognitive impairment," Arch.Neurol., Vol. 58, No. 12, 2001, pp. 1985-1992.
- Prasad, K. N., Cole, W. C., Hovland, A. R., Prasad, K. C., Nahreini, P., Kumar, B., Edwards-Prasad, J., and Andreatta, C. P., "Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale," Curr.Opin.Neurol., Vol. 12, No. 6, 1999, pp. 761-770.
This article was first published in the July/August 2003 issue of International Health News |